ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 143095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 143095; 2) Community: the network communities that were significantly associated with the response to NSC 143095; 3) Molecule: the relationships between components within communities and NSC 143095; 4) MDR: the compounds that were significantly associated with the NSC 143095.

NSC Compound Enrichment Correlation
NSC 726217 Combretastatin A4-analogue 0.00841144976667934 0.40379649
NSC 755880 Mitomycin (USAN) 0.00841144976667934 0.38017459
NSC 762346 Null 0.00841144976667934 0.5607494
NSC 176503 Fastigilin B 0.00888636978630776 0.29058566
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.00888636978630776 0.50489521
NSC 308847 Amonafide 0.00888636978630776 0.57726487
NSC 33530 Null 0.00888636978630776 0.37603139
NSC 382046 Null 0.00888636978630776 0.75364573
NSC 617309 Null 0.00888636978630776 0.32816026
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.00888636978630776 0.20785093
Total:97  Current:28    [First] [Prev] [Next] [Last]